Skip to content

Ginkgo Bioworks DNA Deferred Taxes

Deferred Taxes at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
-$258M+7.5%
Charles River Laboratories logo
Charles River LaboratoriesCRL
-$29.42M-54.5%
TEC
Bio-TechneTECH
$2.84M+153%
Azenta logo
AzentaAZTA
-$5.79M-981%
Revvity logo
RevvityRVTY
-$15.37M+39.9%
Danaher logo
DanaherDHR
$110M-8.9%

Other financials

Income statement

See full
Revenue$19.5M-49.1%
Gross profit$16.4M-52.0%
Operating income-$71.4M+11.9%
Net income-$82.6M+9.2%
EPS (diluted)-$1.42+27.6%

Balance sheet

See full
Cash & equivalents$188.7M-46.9%
Total debt$410.7M-5.5%
Total equity$443.2M-31.6%
Total assets$1.0B-20.1%

Cash flow

See full
Operating cash flow-$46.7M+9.4%
CapEx$1.9M-74.6%
Free cash flow-$48.6M+17.8%

Valuation

See full
Market cap$625.16M+24.6%
Enterprise value$847.19M+45.9%
P/S4.4×+2.2×

Profitability

See full
Operating margin-210.7%+7.6pp
Net margin-215.4%+8.3pp
FCF margin-119%-21.2pp

Returns & leverage

See full
Return on equity-55.8%-1.8pp
Debt / equity0.9×+0.3×
Current ratio5.2×+0.3×

Where this comes from

Reported directly by Ginkgo Bioworks in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.

The official record: Ginkgo Bioworks’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ginkgo Bioworks's deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ginkgo Bioworks's deferred taxes?
Ginkgo Bioworks (DNA) reported deferred taxes of -$341K in Q4 2025.
How has Ginkgo Bioworks's deferred taxes changed year-over-year?
Ginkgo Bioworks's deferred taxes decreased by 45.7% year-over-year, from -$234K to -$341K.
What does deferred taxes mean?
Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.